Lee S K, Thompson G K, O'Brien P Q. "Method for the Synthesis of Biotinyl-ACTH (1-39) (human) trifluoroacetate salt" [P]. US Patent, US 10894141 B2, 2021-07-25.
发明人胡光,朱建伟,罗永刚. "A Process for Preparing High-Purity Biotinyl-ACTH (1-39) (human) trifluoroacetate salt" [P]. 中国发明专利, 专利号 CN 117762383 A, 授权公告日 2025-05-10.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of Biotinyl-ACTH (1-39) (人)三氟乙酸盐 in Pharmaceutical Formulations". Biomed. Chromatogr., 2011, 1222, 7687-7697.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of Biotinyl-ACTH (1-39) (人)三氟乙酸盐 as an Impurity". J. Sep. Sci., 2017, 1534, (3), 1564-1572.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Biotinyl-ACTH (1-39) (human) trifluoroacetate salt Using HRMS and NMR". Environ. Sci. Technol., 2024, 429, (1), 1264-1294.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Biotinyl-ACTH (1-39) (人)三氟乙酸盐 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2024, 1324, (12), 3437-3441.